3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
14
Colorectal Neoplasms
13
Stomach Neoplasms
12
Pancreatic Neoplasms
11
Liver Neoplasms
8
Neuroendocrine Tumors
7
Neoplasm Metastasis
6
Gastrointestinal Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Neoplasms
3
Digestive System Neoplasms
3
Gastrointestinal Stromal Tumors
2
Gastro-enteropancreatic neuroendocrine tumor
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma Of Esophagus
2
Adenocarcinoma
2
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thrombocytosis
1
Stomach Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Salivary Gland Neoplasms
1
Interventions
Ultrasonography
2
Tomography, X-Ray Computed
2
Colonoscopy
2
Blood Specimen Collection
2
tremelimumab
1
peginterferon alfa-2a
1
lenvatinib
1
hepatitis C immune globulin, human
1
fluoromisonidazole
1
epigallocatechin gallate
1
durvalumab
1
babao dan
1
Weights and Measures
1
Vitamin B 6
1
Urination
1
Tomography
1
Tidal Volume
1
Tenofovir
1
Surgical Procedures, Operative
1
Standard of Care
1
Shadowing Technique, Histology
1
Radiomics
1
Propranolol
1
Probiotics
1
Preoperative Exercise
1
Positron-Emission Tomography
1
Portasystemic Shunt, Transjugular Intrahepatic
1
Population Groups
1
Plasmapheresis
1
Oxaliplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Cirrhosis
×
Everolimus
×
Gastrointestinal
×
Clear all
NCT01423708
2012-07-18
EPOCAL
Azienda Ospedaliera di Padova
Phase 2
Unknown
117 enrolled